MedCity News

JUNE 4, 2025

Patients no longer want to rely upon only whatever snippets of information they get from their doctor at an annual or semiannual checkup. Theyre looking for a fully connected patient experience. Healthcare organizations need to know what that looks like, how to build it, and how they fit into the full picture. The post The Connected Patient Experience: 3 Tips to Empower Healthcare Delivery Through Innovation appeared first on MedCity News.

Healthcare 222

Healthcare Healthcare Patients Doctors 222

World of DTC Marketing

JUNE 6, 2025

With reports of budget constraints and layoffs hitting federal agencies like the FDA and CDC, many talented public health professionals are suddenly finding themselves out of work. As they look to the private sector—particularly the pharmaceutical and biotech industries—the question arises: do they possess the right business skills to make a successful transition ?

Pharma 244

Pharma FDA Ethics Government 244

PharmaVoice

JUNE 5, 2025

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

260

260

Fierce Pharma

JUNE 6, 2025

In late April, when Sanofi revealed that it was selling a controlling stake in its consumer health business Opella for 10 billion euros, chief financial officer Francois Roger said that the French drugmaker would “explore external growth opportunities for bolt-on acquisitions.” Just five weeks later, Sanofi has made a deal few would describe as “bolt-on,” as it has bought out Blueprint Medicines for $9.5 billion.

Medicine 204

Medicine 204

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

JUNE 4, 2025

Lucet, a behavioral health company, is acquiring home care company Emcara Health to offer integrated care models. The post Lucet to Acquire Home Care Company Emcara Health appeared first on MedCity News.

264

264

PharmaVoice

JUNE 6, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Pharma 130

Pharma Leads Patients Side effects 130

Fierce Pharma

JUNE 6, 2025

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu looks poised to reach newly diagnosed patients, with efficacy data that live up to the pair’s previous “highly statistically significant” description.

Patients 193

Patients 193

MedCity News

JUNE 5, 2025

Amazon Pharmacy recently launched a new caregiver feature and expanded PillPack to Medicare Part D. The company says the updates will support medication adherence. The post Amazon Pharmacy Brings PillPack to Medicare and Adds Caregiver Feature — Will It Make a Difference? appeared first on MedCity News.

Medical 246

Medical 246

World of DTC Marketing

MAY 31, 2025

Each year, the American Society of Clinical Oncology (ASCO) meeting brings together the brightest minds in cancer research, pharmaceuticals, and patient care to share breakthroughs, data, and hope. And each year, one glaring topic remains conspicuously under-discussed: the brutal, life-altering cost of cancer treatment. We celebrate new therapies. We hear about remarkable survival data.

Insurance 208

Insurance Patients Doctors Medical 208

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

PharmaVoice

JUNE 3, 2025

The pharma giant is betting that Blueprint, whose research revolves around a certain kind of tyrosine kinase, will be a boost to its immunology business.

Pharma 130

Pharma 130

Fierce Pharma

JUNE 6, 2025

How data-driven partnerships and precision engagement are redefining pharma's role in patient care

Pharma 179

Pharma Patients 179

MedCity News

JUNE 2, 2025

The bottom line is that while recognizing there is an issue is vital, too many healthcare organizations are counting on solutions that cannot and will not provide a sufficient line of defense. The post HIPAAs Blind Spot: Its Time to Address Client-Side Attacks appeared first on MedCity News.

Healthcare 262

Healthcare Healthcare 262

World of DTC Marketing

JUNE 3, 2025

It’s easy to get swept up in the hype of the latest miracle drug. Right now, that miracle is Ozempic. Originally developed to treat type 2 diabetes, it’s now making headlines—and billions—for its off-label use in weight loss. Celebrities endorse it. Social media glorifies it. And suddenly, everyone wants a prescription. But here’s the truth: Ozempic is not for everyone.

Medical 211

Medical Side effects Doctors Prescription 211

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Evolve Your Success

JUNE 4, 2025

Want to Win in Medical Sales? Master These Skills First This episode is everything you need to transition from healthcare to medical sales. April Hoffman, a former physical therapist turned medical sales leader, shares how she used her clinical background to break into the industry and thrive. Her story proves that your healthcare experience is not just relevant, its a powerful asset.

Medical sales 130

Medical sales Sales Medical Doctors 130

Fierce Pharma

JUNE 6, 2025

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Pharma 189

Pharma Marketing 189

MedCity News

JUNE 1, 2025

What if the kind of cuts we should be talking about are the ones that actually make care better? Like cutting confusion. Because for many people, the biggest barrier to healthcare access isnt cost or availability its complexity. The post A Call for Healthcare Cuts But Not the Kind Youre Thinking Of appeared first on MedCity News.

Healthcare 240

Healthcare Healthcare Patients 240

World of DTC Marketing

JUNE 4, 2025

In 2025, the cost of employer-sponsored health insurance for a family of four has surged past $35,000 annually. That’s nearly triple the cost from just two decades ago. While wages have grown at a modest pace over the same period, healthcare costs have skyrocketed—leaving families, employers, and our healthcare system struggling to cope under the pressure.

Healthcare 189

Healthcare Healthcare Insurance Medical 189

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaVoice

JUNE 2, 2025

With policy and funding evolving, companies are being forced to rethink strategies.

Marketing 130

Marketing 130

Fierce Pharma

JUNE 6, 2025

Novartis has submitted a request in Delaware federal court urging the judge who oversaw a December patent litigation trial to issue a final decision and verdict on the case before July 15. If it gets its way, Novartis could block generic rival MSN from launching its Entresto copycat until late next year.

171

171

MedCity News

JUNE 5, 2025

Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s strategy for this drug in lung cancer and beyond. The post J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma appeared first on MedCity News.

Biopharma 242

Biopharma Pharma 242

pharmaphorum

JUNE 5, 2025

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people"

101

101

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

Sales Pilot Medical Sales Performance

JUNE 5, 2025

Why "Mastering Medical Sales" Had to Evolve: Your Essential Guide to Today's Healthcare Landscape Why did I rewrite the book on medical sales? The world of medical sales is a dynamic and constantly shifting landscape, far removed from what it was even a decade ago. This is precisely why my book, “ Mastering Medical Sales, ” underwent a complete reimagining to become “Mastering Medical Sales—The Evolution” The original insights, published in 2010, no longer fully capture

Medical sales 100

Medical sales Sales Medical Healthcare 100

Fierce Pharma

JUNE 6, 2025

DeepIntent’s Jay Richetelli discusses the role of AI, data ownership and trust in shaping the next era of pharma marketing

Pharma 164

Pharma Marketing 164

MedCity News

JUNE 2, 2025

The “One Big Beautiful Bill” would codify Individual Coverage Health Reimbursement Arrangements (ICHRAs) the personalized insurance model that has transformed how employers offer health benefits into law as CHOICE Arrangements, or Custom Health Option and Individual Care Expense arrangements. The post A Defining Moment for Employer Health Benefits: How the One Big Beautiful Bill Could Transform Healthcare for Employers appeared first on MedCity News.

Healthcare 247

Healthcare Healthcare Insurance 247

pharmaphorum

JUNE 5, 2025

Novo Nordisk's long-acting injectable Sogroya has been backed for NHS use in young people with growth hormone deficiency

104

104

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

PharmaTimes

JUNE 4, 2025

Treatment provides option for children with growth failure

92

92

Fierce Pharma

JUNE 6, 2025

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, scoring an FDA approval to expand its use to all patients with metastatic castration-sensitive prostate cancer, with or without added chemotherapy.

Sales 164

Sales FDA Patients 164

MedCity News

JUNE 1, 2025

Merck KGaAs pimicotinib led to statistically significant improvement on multiple measures of its Phase 3 test in tenosynovial giant cell tumor, positioning the drug to potentially compete with medications from Daiichi Sankyo and Ono Pharma. The Phase 3 results were presented during the annual meeting of the American Society of Clinical Oncology. The post At ASCO, Merck KGaA Shows How Its Drug Measures Up as Treatment for Rare Type of Tumor appeared first on MedCity News.

Pharma 229

Pharma Medical Biopharma 229